How many insider trades does FilingIQ track for ARDX?

FilingIQ tracks 835 Form 4 insider transactions for ARDX (ARDELYX, INC.), covering filings from Jan 8, 2015 onwards. 34 of those were filed in the last 90 days.

Are ARDX insiders net buyers or net sellers?

Across the full Form 4 history for ARDX, 95 transactions (11%) were open-market purchases and 389 (47%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ARDX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ARDX in?

ARDELYX, INC. (ARDX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.50B.

ARDX insider trading

NasdaqGM Healthcare

ARDELYX, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

835

Last 90 days

Buys / sells

11% / 47%

Market cap

$1.50B

About ARDELYX, INC.

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Company website: www.ardelyx.com

ARDX insider activity at a glance

FilingIQ has scored 835 insider transactions for ARDX since Jan 8, 2015. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 95 open-market purchases and 389 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ARDX insider trades is 54.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ARDX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ARDX?: FilingIQ tracks 835 Form 4 insider transactions for ARDX (ARDELYX, INC.), covering filings from Jan 8, 2015 onwards. 34 of those were filed in the last 90 days.
Are ARDX insiders net buyers or net sellers?: Across the full Form 4 history for ARDX, 95 transactions (11%) were open-market purchases and 389 (47%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ARDX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ARDX in?: ARDELYX, INC. (ARDX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.50B.

Methodology & sources

Every ARDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.